Impact of antithrombotic therapy in the prognosis of atrial fibrillation patients with advanced chronic kidney disease

被引：0
|
作者：
Andreu Cayuelas, J. M. [1 ]
Raposeiras-Roubin, S. [2 ]
Fortuny Frau, E. [3 ]
Garcia Del Egido, A. [4 ]
Seller-Moya, J. [5 ]
Ortiz Cortes, C. [6 ]
Camacho Freire, S. J. [7 ]
Alonso Fernandez, P. [8 ]
Jorge-Perez, P. [9 ]
Lopez-Pais, J. [10 ]
Bravo-Marques, R. [11 ]
Palacios-Rubio, J. [3 ]
Benezet-Mazuecos, J. [12 ]
Cosin-Sales, J. [13 ]
机构：
[1] Gen Univ Hosp Reina Sofia, Murcia, Spain
[2] Alvaro Cunqueiro Hosp, Cardiol, Vigo, Spain
[3] Univ Hosp Son Espases, Cardiol, Palma De Mallorca, Spain
[4] Hosp Leon Complejo Asistencial Univ Leon, Cardiol, Leon, Spain
[5] Hosp Marina Salud, Cardiol, Denia, Spain
[6] Hosp San Pedro Alcantara, Cardiol, Caceres, Spain
[7] Hosp Juan Ramon Jimenez, Cardiol, Huelva, Spain
[8] Hosp Manises, Cardiol, Valencia, Spain
[9] INCANIS Hosp Univ Canarias, Cardiol, San Cristobal la Laguna, Spain
[10] Univ Hosp Santiago de Compostela, Cardiol, Santiago De Compostela, Spain
[11] Hosp Costa del Sol, Cardiol, Marbella, Spain
[12] Univ Hosp Quironsalud Madrid, Cardiol, Madrid, Spain
[13] Hosp Arnau Vilanova, Cardiol, Valencia, Spain
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：649 / 649
页数：1
相关论文
共 50 条
  • [31] Selecting antithrombotic therapy for patients with atrial fibrillation
    Tanaka-Esposito, Christine
    Chung, Mina K.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2015, 82 (01) : 49 - 63
  • [32] Antithrombotic therapy in patients with combined coronary heart disease and atrial fibrillation
    Thompson, Peter L.
    Morton, Allison C.
    PANMINERVA MEDICA, 2016, 58 (01) : 23 - 33
  • [33] Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients
    Hess, Connie N.
    Broderick, Samuel
    Piccini, Jonathan P.
    Alexander, Karen P.
    Newby, L. Kristin
    Shaw, Linda K.
    Mahaffey, Kenneth W.
    Alexander, John H.
    Peterson, Eric D.
    Granger, Christopher B.
    Lopes, Renato D.
    AMERICAN HEART JOURNAL, 2012, 164 (04) : 607 - 615
  • [34] The risks and benefits of antithrombotic therapy in chronic atrial fibrillation
    Hankey, GJ
    Gray, NJ
    MEDICAL JOURNAL OF AUSTRALIA, 1996, 164 (10) : 624 - 626
  • [35] Chronic kidney disease in atrial fibrillation: risks of stroke and bleeding and the effect of antithrombotic treatment
    Olesen, J. B.
    Lip, G. Y. H.
    Kamper, A. -L.
    Hommel, K.
    Kober, L.
    Lane, D. A.
    Lindhardsen, J.
    Gislason, G. H.
    Torp-Pedersen, C.
    EUROPEAN HEART JOURNAL, 2012, 33 : 176 - 176
  • [36] Prognosis and antithrombotic therapy of patients with atrial fibrillation after undergoing percutaneous coronary intervention)
    Tanabe, Y.
    Tejima, T.
    Kitamura, T.
    Hojo, R.
    Komiyama, K.
    Fukamizu, S.
    Sakurada, H.
    Kobayashi, Y.
    EUROPEAN HEART JOURNAL, 2013, 34 : 353 - 354
  • [37] Influence of Chronic Kidney Disease on Warfarin Therapy for Atrial Fibrillation
    Vaduganathan, Muthiah
    Greene, Stephen J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (24): : 2541 - 2542
  • [38] Impact of different antithrombotic therapystrategy on prognosis in coronary heart disease patients combined with atrial fibrillation:a meta analysis
    袁晨
    China Medical Abstracts(Internal Medicine), 2017, 34 (03) : 160 - 160
  • [39] Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs
    Kooiman, J.
    van de Peppel, W. R.
    van der Meer, F. J. M.
    Huisman, M. V.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (08) : 1652 - 1653
  • [40] SAFETY OUTCOMES OF ORAL ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE
    Igamberdieva, Ranokhon
    Abdullaev, Sherzod
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I141 - I141
12345